During the past decade, Four Peaks Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Four Peaks Neurology" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Four Peaks Neurology" are "Alzheimer's Disease" (2 trials) and "Ischemic Stroke" (1 trials). Many other conditions were trialed in "Four Peaks Neurology" in a lesser frequency.

Most popular intervention types in "Four Peaks Neurology" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Brain PET Scan" (1 trials), "Flortaucipir F18" (1 trials), "Lanabecestat" (1 trials), "Placebo" (1 trials) and "TF0023" (1 trials). Other intervention names were less common.

The vast majority of trials in "Four Peaks Neurology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Four Peaks Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Four Peaks Neurology, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Four Peaks Neurology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".